Pathogenic germline TP53 mutations in adult sarcoma patients; implications for treatment and screening – description of an upcoming project by Mahendran K, Ballinger M, Kirk J, Thomas D, Tattersall M

Get full text

Recommended guidelines for validation, quality control, and reporting of TP53 variants in clinical practice by Leroy, B, Ballinger, M, Baran-Marszak, F, Bond, G, Braithwaite, A, Concin, N, Donehower, L, El-Deiry, W, Fenaux, P, Gaidano, G, Langerød, A, Hellstrom-Lindberg, E, Iggo, R, Lehmann-Che, J, Mai, P, Malkin, D, Moll, U, Myers, J, Nichols, K, Pospisilova, S, Ashton-Prolla, P, Rossi, D, Savage, S, Strong, L, Tonin, P, Zeillinger, R, Zenz, T, Fraumeni, J, Taschner, P, Hainaut, P, Soussi, T